Tenon Medical Obtains Approval for Two Additional European Patents for Catamaran SI Joint Fixation Device
Los Gatos, CA – March 10, 2025
Tenon Medical, Inc. (NASDAQ: TNON), a leading medical device company specializing in the development and commercialization of innovative solutions for patients with certain Sacroiliac Joint (SIJ) disorders, is thrilled to announce that the European Patent Office has granted approval for two additional patents related to Tenon’s novel Catamaran® SI Joint Fixation Device. This marks a significant milestone for Tenon as it continues to expand its intellectual property portfolio and strengthen its position in the growing SIJ market.
About the Catamaran SI Joint Fixation Device
The Catamaran SI Joint Fixation Device is a cutting-edge medical innovation designed to address the complex needs of patients suffering from SIJ disorders. This minimally invasive, dual-pronged prosthesis is engineered to provide improved stability, motion, and pain relief for patients. The device’s unique design, which resembles a catamaran sailboat, allows for biomechanical advantages, enabling the patient’s body to naturally adapt and adapt to their unique anatomy.
Impact on Tenon and the Industry
The approval of these two European patents further validates the novelty and potential of Tenon’s Catamaran SI Joint Fixation Device. Tenon’s intellectual property portfolio now includes a total of six granted patents and numerous pending applications, providing the Company with a competitive edge in the SIJ market. This development is expected to enhance Tenon’s ability to attract new customers, collaborate with key opinion leaders, and expand its global footprint.
Effect on Patients and the World
For millions of individuals worldwide who suffer from debilitating SIJ disorders, this news signifies a potential breakthrough in their journey towards pain relief and improved mobility. The Catamaran SI Joint Fixation Device offers a minimally invasive, durable, and effective solution that can help patients regain their quality of life. The approval of these European patents is a testament to Tenon’s commitment to advancing medical technology and bringing innovative treatments to those in need.
Quote from Tenon’s Co-Founder and CTO
“The Tenon Medical team is pleased to receive recognition from the European Community for our novel Catamaran® SI joint prostheses,” commented Richard Ginn, Co-Founder and Chief Technology Officer of Tenon Medical. “Our team is dedicated to transforming care for patients suffering from SIJ disorders, and these patents are an important step towards bringing our innovative technology to more patients across Europe and beyond.”
- Tenon Medical announces approval of two additional European patents for Catamaran SI Joint Fixation Device
- Device offers improved stability, motion, and pain relief for patients with SIJ disorders
- Patents further validate the novelty and potential of Tenon’s technology
- Impact on patients: potential breakthrough for millions suffering from SIJ disorders
- Impact on Tenon: competitive edge, ability to expand global footprint
- Impact on the industry: innovation and advancement in medical technology
In conclusion, the approval of these two European patents for Tenon Medical’s Catamaran SI Joint Fixation Device marks a significant milestone in the Company’s mission to transform care for patients suffering from SIJ disorders. This development further validates the novelty and potential of Tenon’s technology and is expected to have a positive impact on the Company, patients, and the medical industry as a whole. Tenon remains committed to advancing medical technology and bringing innovative treatments to those in need.
The future looks bright for Tenon Medical, as the Company continues to push the boundaries of medical innovation and improve the lives of patients around the world.
